These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20163903)

  • 21. Industry support of graduate medical education in surgery.
    Nakayama DK; Bozeman AP
    Am Surg; 2009 May; 75(5):395-400. PubMed ID: 19445290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Is it pertinent to investigate the relations between physicians and the drug industry].
    Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
    Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intersectorial co-operation in psychiatry].
    Kistrup M; Madsen J; Aggernaes KH; Wang AG
    Ugeskr Laeger; 2009 Nov; 171(48):3514-8. PubMed ID: 19944050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical companies and Italian Regional Governments: managing relationships in an increasing institutional complexity.
    Compagni A; Cavalli L; Jommi C
    Health Policy; 2008 Sep; 87(3):333-41. PubMed ID: 18384907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dangerous liaisons?
    Legge A
    Nurs Times; 2000 Jun 22-28; 96(25):30-1. PubMed ID: 11962979
    [No Abstract]   [Full Text] [Related]  

  • 26. [Relationships between patient associations and companies: ethical aspects].
    Roche G
    Presse Med; 2012 May; 41 Suppl 1():S45-7. PubMed ID: 22459992
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmaceutical industry support and residency education: a survey of internal medicine program directors.
    Loertscher LL; Halvorsen AJ; Beasley BW; Holmboe ES; Kolars JC; McDonald FS
    Arch Intern Med; 2010 Feb; 170(4):356-62. PubMed ID: 20177039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mental health: integrated network and family-oriented model for co-operation between mental health patients, adult mental health services and social services.
    Piippo J; Aaltonen J
    J Clin Nurs; 2004 Oct; 13(7):876-85. PubMed ID: 15361161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-operation as a strategy for provision of welfare services--a study of a rehabilitation project in Sweden.
    Norman C; Axelsson R
    Eur J Public Health; 2007 Oct; 17(5):532-6. PubMed ID: 17392292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK.
    Rickard E; Ozieranski P; Mulinari S
    Health Policy; 2019 Dec; 123(12):1244-1250. PubMed ID: 31455562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of relational activities on HMO organizational outcomes.
    Doucette WR
    Am J Manag Care; 1999 Aug; 5(8):1025-34. PubMed ID: 10558126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of research in a technical assistance agency: the case of the 'German Agency for Technical Co-operation'.
    Horchler S; Gerhardus A; Schmidt-Ehry G; Schmidt-Ehry B; Korte R; Mitra SK; Sauerborn R
    Health Policy; 2004 Nov; 70(2):229-41. PubMed ID: 15364152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescription assistance programs: options for assisting the uninsured and underinsured.
    Turowski RC; Raskay-Bianco MM; Visconti JA
    Hosp Pharm; 1993 Oct; 28(10):948, 951-5, 958-68. PubMed ID: 10129140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to manage conflicts of interest with industry?
    Schowalter JE
    Int Rev Psychiatry; 2008 Apr; 20(2):127-33. PubMed ID: 18386202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of drug promotion on prescribing habits of doctors in a teaching hospital.
    Akande TM; Aderibigbe SA
    Afr J Med Med Sci; 2007 Sep; 36(3):207-11. PubMed ID: 18390058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The promise and peril of direct-to-consumer prescription drug promotion on the Internet.
    Hall TS
    DePaul J Health Care Law; 2003; 7(1):1-41. PubMed ID: 15468476
    [No Abstract]   [Full Text] [Related]  

  • 37. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey.
    Rutledge P; Crookes D; McKinstry B; Maxwell SR
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):663-7. PubMed ID: 14762982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dealing with drug dependency: a commentary on ILAE's partnership with the pharmaceutical industry.
    Avanzini G; Engel J
    Epilepsia; 2007 Oct; 48(10):1821-4. PubMed ID: 17683507
    [No Abstract]   [Full Text] [Related]  

  • 39. [The influence of the pharmaceutical industry on treatment guidelines].
    Kramers C; Wuis E; Schouwenberg B
    Ned Tijdschr Geneeskd; 2008 Jan; 152(2):114; author reply 114. PubMed ID: 18265803
    [No Abstract]   [Full Text] [Related]  

  • 40. Medical ethics: funding the discourse.
    Roy N
    Issues Med Ethics; 2002; 10(2):20-1. PubMed ID: 16334924
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.